α-Antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population
- 9 January 1998
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 240 (2), 107-109
- https://doi.org/10.1016/s0304-3940(97)00924-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Regional cerebral glucose utilization is modulated by the dosage of apolipoprotein E type 4 allele and α1-antichymotrypsin type A allele in Alzheimerʼs diseaseNeuroReport, 1997
- The genotype 2/2 of the presenilin-1 polymorphism is decreased in Spanish early-onset Alzheimer's diseaseNeuroscience Letters, 1997
- No Genetic Effect of α1-Antichymotrypsin in Alzheimer DiseaseGenomics, 1996
- High apolipoprotein E ε4 allele frequency in Age‐related memory declineAnnals of Neurology, 1996
- A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphismNature Genetics, 1995
- Apolipoprotein E4 allele frequency in Spanish Alzheimer and control casesNeuroscience Letters, 1995
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- ?1-Antichymotrypsin Binding to Alzheimer A? Peptides Is Sequence Specific and Induces Fibril Disaggregation In VitroJournal of Neurochemistry, 1993
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's diseaseCell, 1988